Atrial fibrillation: Rate or rhythm control - Individual patient management;Vorhofflimmern: Frequenz- oder rhythmuskontrolle - Welche strategie für welchen patienten?

Zeitschrift fur Kardiologie

Volumn 94, Issue SUPPL. 4, 2005, Pages

  Schwab, J O ^a   Luderitz B ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Antiarrhythmic drug therapy; Anticoagulation; Atrial fibrillation; Interventional catheter guided therapy; Rate control; Rhythm control

Indexed keywords

ACETYLSALICYLIC ACID; AJMALINE; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; FLECAINIDE; LIDOCAINE; METOPROLOL; MEXILETINE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL;

ANTICOAGULATION; ARTICLE; CATHETER ABLATION; COHORT ANALYSIS; HEALTH CARE ORGANIZATION; HEART ATRIUM FIBRILLATION; HEART RATE; HEART RHYTHM; HUMAN; MEDICAL DECISION MAKING; MEDICAL SOCIETY; PHYSICIAN; PRACTICE GUIDELINE; QUALITY OF LIFE; SINUS RHYTHM; THROMBOEMBOLISM;

ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; CLINICAL TRIALS; COMBINED MODALITY THERAPY; ELECTROCARDIOGRAPHY; HEART RATE; HUMANS; SURVIVAL RATE; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 30944461573     PISSN: 03005860     EISSN: 14351285     Source Type: Journal    
DOI: 10.1007/s00392-005-1412-x     Document Type: Article

References (9)

1. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation (2001) Eur Heart J 22:1852-1923
2. Bielik H, Schrickel J, Shlevkov N, Schwab JO, Bitzen A, Lüderitz B, Lewalter T (2005) Pharmakologische und ablative Hybridtherapie des Vorhofflimmerns - Lebensqualität und Arrhythmie-bezogene Symptomatik im Langzeitverlauf. Z Kardiol 94:564-569
3. Falk RH (2005) Is rate control or rhythm control preferable in patients with atrial fibrillation? Rate control is preferable to rhythm control in the majority of patients with atrial fibrillation. Circulation 111:3141-3157
4. Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, Breithardt G (2004) Prevention of atrial fibrillation after cardioversion investigators. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J 25:1385-1394
5. Lévy S, Camm AJ, Saksena S, Aliot E, Breithardt G, Crijns H, Davies W, Kay N, Prystowsky E, Sutton R, Waldo A, Wyse DG (2003) Working group on arrhythmias, working group on cardiac pacing of the ESC, NASPE. International consensus on nomenclature and classification of atrial fibrillation. Europace 5:119-122
6. Lewalter T, Lüderitz B (2005) Vorhofflimmern - Interventionelle Differentialtherapie unter besonderer Berücksichtigung des Lebensalters. Dtsch Med Wochenschr 130:721-725
7. Patten M, Maas R, Bauer P, Luderitz B, Sonntag F, Dluzniewski M, Hatala R, Opolski G, Muller HW, Meinertz T (2004) SOPAT Investigators. Suppression of paroxysmal atrial tachyarrhythmias - results of the SOPAT trial. Eur Heart J 25:1395-1404
8. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ (2002) Rate control versus electrical cardioversion for persistent atrial fibrillation study group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834-1840
9. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD (2002) Atrial fibrillation follow-up investigation of rhythm management (AFFIRM) investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825-1833